Published

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Medical science monitor: international medical journal of experimental and clinical research
Date: 2025-08-09
Source: PubMed
DOI: 10.12659/msm.948302
PubMed: 40781763

Authors

Silczuk A Madejek RJ Koweszko T Mularczyk-Tomczewska P Adamska E Gujski M Szulc A

Watch author

Derived topics and classifications

psilocybin Depression PTSD Addiction OCD Neuroplasticity Mechanism of Action Clinical Trial Review Article Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 2 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Bridging the reporting gap: Application of the ReSPCT guidelines in psilocybin clinical trial protocols2026-04-01 Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.2025-08-09

Related papers

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol DependenceClinicalTrials.gov · 2022-11-08 Psilocybin-assisted neurofeedback for the improvement of executive functions: a randomized semi-naturalistic-lab feasibility study.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024-12-02 Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term MeditatorsClinicalTrials.gov · 2014-05-20 Crystal structures of the Teonanácatl hallucinogens. Part I. Psilocybin C12 H17 N2 O4 PJournal of the Chemical Society Perkin Transactions 2 · 1974-01-01 Crystal structures of the Teonanácatl hallucinogens. Part II. Psilocin, C12 H15 N2 OJ. Chem. Soc., Perkin Trans. 2 · 1974-01-01 Occurrence of psilocybin in the sporophores of Psilocybe semilanceataTransactions of the British Mycological Society · 1969-10-01